A B S T R A C T It has been suggested that the phorbol ester tumor promoters act via the receptor-effector system for epidermal growth factor (EGF), since they interact with the EGF receptor system and mimic many ofthe effects of EGF in cultured cells. We have studied the interaction of phorbol esters with the EGF-responsive MCF-7 human breast cancer cell line. Simi 
A B S T R A C T It has been suggested that the phorbol ester tumor promoters act via the receptor-effector system for epidermal growth factor (EGF), since they interact with the EGF receptor system and mimic many ofthe effects of EGF in cultured cells. We have studied the interaction of phorbol esters with the EGF-responsive MCF-7 human breast cancer cell line. Similar to other systems, phorbol esters inhibit EGF binding in MCF-7 cells in a manner paralleling their potency as tumor promoters in mice. The effect is specific for EGF since the membrane binding of insulin is unaffected. Like EGF, the potent phorbol ester 12-0-tetradecanoyl-13-phorbol acetate (TPA) stimulates protein synthesis as indicated by a twofold increase in [3H]leucine incorporation into protein after 24 h in TPA. Cell morphology, however, is significantly different with TPA treatment. After 24-48 h in TPA, cells become markedly enlarged with increased cytoplasmic vacuolization and increased membrane microvilli. This is reflected in a fourfold increase in the protein/DNA ratio (control 13.1; TPA 55.9). Furthermore, TPA inhibits cell division in media with or without serum, and prevents growth stimulation by EGF. Low TPA concentrations (1.0 ng/ml) are active, and 10 nglml results in maximal inhibition of cell replication. Other phorbol esters inhibit MCF-7 cells relative to their tumor promoting activity in vivo and their ability to inhibit EGF binding in these cells. After 24 h in TPA, incorporation of [3H]thymidine into DNA is markedly reduced and the thymidine labeling index falls (33% to 2%) indicating very few S-phase cells. Growth inhibition is reversible by removing TPA from the medium.
INTRODUCTION
The active components of croton oil, diesters of the diterpine alcohol, phorbol, are potent tumor-promoters in the two-stage mouse skin carcinogenesis model (1) . The phorbol esters themselves are not carcinogens, but application ofthese compounds after a suboptimal dose of a chemical carcinogen results in the growth of tumors.
Studies in vitro have revealed a variety of interesting effects of these tumor promoters on cultured cells. In normal cells the phorbol esters induce changes similar to those observed in cells transformed by chemical or viral carcinogens. In transformed cells many of the characteristics of transformation are exaggerated. These include altered cell morphology (2, 3) , increased uptake of small molecules (2) (3) (4) , alterations of the cell membrane (4, 5) , increased prostaglandin and polyamine synthesis (6) (7) (8) , enhanced DNA synthesis and cell division (3, (9) (10) (11) , and increased production of plasminogen activator (11, 12) . Furthermore, in most models studied phorbol esters inhibit terminal differentiation (2, 13) . The pleiotypic responses induced by different phorbol esters in vitro are directly proportional to their potency as tumor promoters in vivo suggesting that these events may be important for the activitv of these compounds.
The mechanism of tumor promotion is of obvious importance but at present has not been well defined.
Lee and Weinstein have postulated that the tumor promoting activity and the pleiotypic effects of' phorbol esters may be due to the ability of these compouinds to interact with the receptor-effector system of an endogenous growth factor such as epidermal growth factor (EGF)1 (11, 14) . Their hypothesis is based on the observations that phorbol esters specifically inhibit receptor binding of EGF, indicating that they interact directly or indirectly with the EGF receptor domaiin (15, 16) and that phorbol esters share many of the biological properties of EGF in cultured cells (4, 11, 17) . Furthermore, EGF has been reported to promote tumor carcinogenesis in mouise skin (18) . More recent evidence suLggests that the effect of' the phorbol esters on EGF receptor binding is indirect and not the result of an interaction with the active binding site (14, 19, 20) .
We have receently shown that growth of the ctultured human breast cancer cell line, MCF-7, is sensitive to physiological (1-10 ng/ml) conceentrationis of'EGF (21) . In fact, EGF may be recluire(l for the long-term growth of' these cells in defined serumless meditum (22) . Furtlhermore, these cells conitaini specific high affinity receptors f'or EGF.2 In the present stutdies we have used these human-derived cells to further investigate the possibility that these tu-mor promoters and EGF miay have acliommon mechanism of action. gltutamiinle (0.6 g/liter), penicillin (62 mg/liter), streptonmyein (130 mg/liter), instulin (1.0 nM), and 5% calf'serum, and grown to near confluenice. The mediumil was replaced with serum andl hormone-free mediumnl f'or 24 h, and theni changed again to IMEM without or with phorbol esters solubilized in acetone. An equiivalent amiiouniit of acetone (final concentration, 0.1%) w,vas addedl to controls and had no effect on binding. Af'ter 2 h at 37°C, the mediumil was discarded and the monolayers vashed twice with a total of 8 ml of' binding medium (IMEM, 0.1% bovine seruim albtumin, 10 mnM Hepes). Fresl lbincing Imlediuim was theni added (1.4 ml in four well dishes or 0.4 ml in six well dishes).
METHODS
1251-labeled porcine insuilin (130-200 ,uCi/ug) or mouse EGF (40-100,xCi/ug) were prepared by described modificationls of the chloramiiine T method (27) (28) (29) . Labeled instulini (120 pg/ml) or EGF (60 pg/mIl) were added to the cells in a 50 ,ul svol for 15 anid 30 min, respectively, in a humidified incubator vith 5% CO2 at 37°C. Under these conditions insuilin binding reaclhes a Imlaximiumtill between 15 and 30 mm and EGF binding reaches a milaxiimiluImi between 30 anid 60 min. After the incubation, the binding mlediumiii was rapidly aspirated and the monolavers washedl three times witlh a total of 12 ml of' iced phosphate-l)ufferecl salinie with 0.1% bovine serum albumin to remove Itnbotliu( ligand. The cells were harvested by suspenision in 10.02% EDTA in phosphate-buffered saline and the cell bound radioactivity determiinledl in a Searle autogammiiiia counter (Searle Radiographics Inc., Des Plaines, Ill.). Specific binding was defined as the total radioactivity bounid minus the amounit bound in the presence of excess unlabeled hormiionie (insulini, 6 ,ig/ml; EGF, 0.6 ,ug/ml) and was expressed per 10 cells. Nonspecific binding for EGF and insulin rel)resented <3 anid 20% of' the total coun lts bound, respectivelv. Medium fromii cells incubated witlh labeled hormone only was saved for estimation of' degradation by TCA precipitability (insulin) or by columnill chromatography on Sephadex G-50 (EGF).
Other characteristics of' tle insulin receptor in these cells have been published (26). EGF receptor binding in these cells demonstrates temperatture dependence, saturability, reversibility, and high affinity:2 half-maximal displacement of labeled tracer EGF is observed with a concentration of unlabeled EGF that results in approximately half-maximal biological activity (2.0 ng/ml, 0.33 nM). Insulini, fibroblast growth factor, prolactin, and growth hormone do not compete f'or EGF binding.
Cell growth studies. Cells were plated replicately in 100-mmn petri dishes (Falconi Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif:) at concentrations of 0.5-1.1 x 105 cells/dislh in growth medium containing 5% calf serum pluts insulin (1.0 nNI). h later the medium was changed to serumil and hormone-f'ree medium for an additional 24 h. Hormones and/or phorbol esters were then added directly to the dishes at the indicated concentrations. An equivalent volume of acetone was added to controls and had no effect on growth. Cells were f'ed with identical fresh medium every 2 or 3 d. Total DNA (30) , proteini (31) , and hemocytometer cell counts were performed as parameters of cell growth. In somne experiments the effect of phorbol esters on cell growth was measuired in cells growing in medium stupplemenited with 5% calf serumil.
Studies of mnacromzolecular synthesis anid thymnidine labelitng index (TLI). The rates ofprotein and DNA synthesis were estimiiated by the incorporation of labeled precursors into TCA-precipitable material as described (25, 26) . MCF-7 cells were replicately plated to a subconfluent density (3 x 105 cells per dish) in multiwell plates as described above. 24 h later the medium was changed to serum-free IMEM with 0.1% BSA for an additional 24 h. TPA or acetone (controls) were then addecl directly to the wells, and 22 h later [3H]thymidine (0.5 ,Ci/ml) or [14C]leucine (0.5 /LCi/ml) were added for a 2-h pulse. The cells were harvested on ice, an aliquot taken for DNA determination (30) , and the remaining cells disrupted by sonicating for 3 s in a Heat Systenms-Ultrasonics (Plainview, N. Y.) sonicator with a microtip at the lowest setting. Preciursor inicorporation was determined by measuring the radioactivity precipitated in 10% TCA after collection on .Millipore filters (0.45 ,tum, type HA; Millipore Corp., Bedford, Mass.). Incorporation was linear under the conditions empIloyed.
The TLI was determined autoradiographically by the described (21) modification of the method of Livingston et al. (32) . The TLI (labeled/unlabeled cells) was calculated by counting the fraction of intact cells containing eight or more grains over the niucleuis. Background counts were always <5 grainis/nucXleuis.
Ultrastructural studies. Transmiiission and scanning electron microscopy were performed by published methods (33) except that 3% glutaraldehyde in 0.1 M sodium cacodylate, pH 7.4, was used for primary fixation.
RESULTS
EGF and inisulini binding. Similar to reports studying other cell types, a 2-h preincubation with phorbol esters inhibited the binding of EGF but not insulin to MCF-7 breast cancer cells (Fig. 1) . PDA, a weak tumor promoter, had no effect on EGF binding, but the two potent tumor promoters, TPA and PDD, were potent inhibitors. Binding was markedly reduced with a PDD or TPA concentration of only 10 ng/ml, a concentration which also resulted in maximal biological effects (see below).
Inhibition of binding by TPA was apparent when TPA was added simultaneously to the binding assay (Fig. 2 ). In this experiment in which unlabeled EGF was used to compete with tracer EGF for receptor, a 2-h preincubation of the cells with TPA reduced binding to that comparable to nonspecific binding at all concentrations of EGF. Addition of TPA at the start of the binding assay also significantly reduced binding but to to a lesser extent. Thus, the effect of TPA on binding occurred long before the TPA-induced changes in cell morphology (see below). The phorbol esters had no effect on degradation of EGF or insulin. Media degradation, estimated by measuring the TCA-soluble fraction (insulin) or by calculating the fraction appearing in the small molecular weight peak after Sephadex G-50 chromatography (EGF), were <5% in both control and TPA-treated dishes.
Cell morphology. Although the phorbol esters interacted (directly or indirectly) with the EGF receptor, their effects on cell morphology and growth (see below) were markedly different from that of EGF (Fig.  3) . EGF (Fig. 3B) had a minimal effect on cell size and shape compared to controls (Fig. 3A) dramatic effect on cell morphology (Fig. 3C ). The cells markedly enlarged and became more flattened in shape with prominent intercellular attachments. The enlargement was mainly due to an increase in the cytoplasm to nucleus ratio, which is consistent with the increased protein: DNA ratio described below. Striking vacuolization was present in some cells but no dome formation was seen. Although the cells had reached a confluent density, in the presence of TPA a significant reduction from controls in cell number was observed. These data are quantified in Fig. 4 . Scanning electron microscopy (Figs. 3D-F) revealed a dramatic increase in microvilli in the TPA-treated cells suggesting increased secretory or adsorptive activity. Transmission electron microscopy, (not shown) confirmed the presence of numerous microvilli in TPA-treated cells and, in addition, revealed a more intimate relationship between endoplasmic reticulum and mitochondria in these cells compared to that in controls or with EGF. These (Fig. 1) .
The phorbol ester effects on MCF-7 cell morphology and growth are consistent with the effects on precursor incorporation into macromolecules and the TLI (Table  I) . A 24-h incubation with TPA increased the incorporation of labeled leuicine into protein twofold above controls suggesting increased protein synthesis and consistent with the increase in protein content noted above (Fig. 4C) the culture me-
The effect of TPA was also examined in two other ,GF and TPA re-human breast cancer cell lines (Table III) . In this exical to cells incu-periment cells were incubated with or without TPA for 3 days. TPA inhibited cell replication in all three a 6-d incubation lines studied as shown by the reduction in DNA conmeasured by cell tent. The marked change in the protein: DNA ratio, l per replicately however, was seen only in the MCF-7 and ZR75-1 Js. 4A, B, and C, cells and not in the MDA-MB-231 line. 21, 25) , EGF and All of the above experiments were performed with th two-to three-cells growing in serum-free medium. However, ed in serum-free identical results were obtained when MCF-7 cells Ia markedly dif-growing under optimal conditions (5% calf serum) were icantly inhibited incubated with TPA. In either case cell replication was y more than 50%. blocked and protein synthesis was stimulated resulting i by TPA indicat-in a hypertrophied cell. After 10-12 d of continuous tent per cell (see TPA treatment, cell size diminished, and the cells cked the stimula-began to detach from the dish. We could not reverse the despite the fact TPA effect by removing the TPA containing medium itor binding. The after 48 h, washing the cells, and refeeding with fresh the addition of a serum-free medium (Fig. 6) . However, cell proliferail). No additional tion was restored by removing the medium with TPA higher TPA con-and refeeding with a fresh medium containing 5% serum. Thus, the effects of TPA on the MCF-7 cells ology, inhibition are reversible but require removal of TPA from the cell iorbol esters was environment and addition of one or more components portional to their present in serum.
.5). DNA content PDD-treated cul-DISCUSSION i with the weak f PDD to inhibit In general, the phorbol esters have been found to proit EGF receptor mote the characteristic features of a transformed or malignant phenotype in cultured cells. They interact FIGURE 3 Effect of TPA and EGF on MCF-7 cell morphology. Cells were replicately plated and then changed to serum-free medium as described in Methods. Acetone (controls), EGF (10 ng/ml), or TPA (10 ng/ml) were added directly to the culture dishes in 50 ,l vol. Cells were fed with identical fresh medium on alternate days. A, B, and C demonstrate the appearance of MCF-7 cells under a polarizing microscope (x220) after 6 d incuibation with control, EGF, or TPA, respectively. D, E, and F are scanning electronmicrographs (x2700) of control, EGF-, and TPAtreated cells after 4 d of incuLbation.
specifically with the receptor system for EGF and share many of the biological properties of this hormone leading to speculation that tumor promotion may be accomplished through the EGF biochemical effector system.
Our studies suggest that the relationship between the phorbol esters and the EGF receptor-effector system is much more complex and that alternative pathways of action for the tumor promoters must be considered. TPA (ng/ml) 100 FIGURE 4 Effect of TPA on cell growth. MCF-7 cells were plated as described in Fig. 3 and incubated in serum-free medium with acetone (0.1%, controls), EGF (10 ng/ml), and insulin (6 ng/ml) with and without TPA at the concentrations shown. Fresh identical medium was exchanged for spent medium on altemate days. On day 6 cells were harvested and cell number (A), total DNA (B), and total protein (C) per dish were measured as described in Methods. Values are the means of quadruplicates. SE < 5% in every case. The differences observed with TPA are all highly significant (P < 0.001). (13, 19, 20) . These studies suggest that phorbol esters interact indirectly with the EGF receptor system. They could bind to a nonactive site on the EGF receptor leading to a confirmational change with a resultant decrease in the receptor number or affinity for EGF. Alternatively, the effects on EGF binding could result from a more generalized membrane alteration with secondary effects on the EGF receptor.
It is interesting to speculate that the inhibition ofcell proliferation and stimulation of protein synthesis observed in our human breast cancer cells in response to these tumor promoters is due to activation of a pathway leading to differentiation. The phorbol esters appear to interact with a mechanism involved with control of differentiation in other in vitro animal model systems, but inhibition of spontaneous and induced differentiation has usually resulted (34) (35) (36) (37) (38) (39) (40) (41) (42) . Different results have been reported with human-derived cells. Human promyelocytic leukemia cells (HL60) and human melanoma cells have been shown to acquire differentiated functions and to slow their proliferative rate in response to phorbol esters (43) (44) (45) (46) (47) . Further investigation will be required to determine whether the morphological and biochemical changes induced by phorbol esters in these human breast cancer cells represent features of a more differentiated phenotype.
These studies suggest that the phorbol ester tumor promoters interact with a site on the plasma membrane of cells that indirectly alters the binding of EGF to its receptor. This plasma membrane-phorbol ester interaction can then alter cell morphology, cell replication, the degree of differentiation, and other cell functions in a manner partially dependent on the tissue and species involved. The growth inhibition and stimulation of differentiation of several human neoplastic cell types induced by these compounds suggests that the antineoplastic properties of these "tumor promoters" deserve additional study.
